Home / Resources / Preclinical resources

前臨床

最新のリソース

All Preclinical

Best Practices for Visualization of Nonclinical Study Data in SEND Format (and Beyond)

Are you prepared for the FDA’s phase out of animal tests for mAbs?

Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling

Featured resource

All Preclinical

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

2025年4月18日 What’s next for drug development? Recapping our MIDD in the age of AI webinarMIDD has transformed the pharmaceutical landscape—empowering scientists and…

前臨床試験リソース

All Preclinical

Write Quicker PBPK Reports with the Simcyp Report Assistant

2025年4月11日 Writing a report for PBPK models can be an onerous process, especially when the report requires the compilation of data from…

All Preclinical

Certainty US 2025

May 7-8, 2025 | Philadelphia, PA

How Certara MIDD Experts Overcame Client Regulatory Challenges

Certara’s Model-Informed Drug Development (MIDD) approach leverages an integrated, quantitative systems methodology to accelerate regulatory approval and commercial success while…

Phoenix 8.6の新しい機能?

日付：To be announced | Coming in Q2 2025Solutions: Preclinical, Early Clinical, Late Clinical, RegulatoryProducts: Phoenix™ Get a first look…

Latest preclinical blogs

All Preclinical - Blog

医薬品開発におけるPK/PDモデリングのための機械学習

米国FDAのモデルに基づく医薬品開発と対になったパイロットプログラムが治験依頼者を助ける方法

Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis

Measuring metabolites in index clinical DDI studies

Key development considerations for cell therapies

PBPK Modeling to Support Bioequivalence & Generic Product Approvals

以下のイベントで弊社のエキスパートをご紹介

All Conference - Preclinical LP

DIA Annual Meeting 2025

June 15-19, 2025 - Washington, DC - Booth #1831

All Preclinical resources

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

Drug Development Support, Modeling and Simulation, Blog

Best Practices for Visualization of Nonclinical Study Data in SEND Format (and Beyond)

Certara Products - SEND Explorer, Webinar

Are you prepared for the FDA’s phase out of animal tests for mAbs?

Homepage Latest, Webinar - Resources LP - Upcoming, Webinar

Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling

Webinar - Resources LP - Upcoming, Webinar

Write Quicker PBPK Reports with the Simcyp Report Assistant

Certara Products - Simcyp, Modeling and Simulation - PBPK, Blog

How Certara MIDD Experts Overcame Client Regulatory Challenges

Homepage Latest, Case Study

Phoenix 8.6の新しい機能?

ウェビナー

Mechanistic Modeling to Meet Challenges in ADC Development

Modeling and Simulation - QSP, Blog

Unlocking the Power of Oligonucleotide Therapeutics: A Model-Informed Approach with Certara & Ionis

Clinical Pharmacology, Webinar

Unlocking Success with Phoenix Hosted: Real-World Customer Stories

Certara Products - Phoenix, Case Study

Calculating AUC (Linear and Log-linear)

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog, Knowledge Base

Accumulation: What It Means and How to Calculate It

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog, Knowledge Base

1
2
3
…
56
›

ニュースレターを購読

今すぐ登録：医薬品開発の革新は、私たちの目標を超えた情熱そのものです。最新情報を入手し、共に科学の限界を切り拓いていきましょう。

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software